ATE400660T1 - Vektoren für genmutagenese und genentdeckung - Google Patents

Vektoren für genmutagenese und genentdeckung

Info

Publication number
ATE400660T1
ATE400660T1 AT99914126T AT99914126T ATE400660T1 AT E400660 T1 ATE400660 T1 AT E400660T1 AT 99914126 T AT99914126 T AT 99914126T AT 99914126 T AT99914126 T AT 99914126T AT E400660 T1 ATE400660 T1 AT E400660T1
Authority
AT
Austria
Prior art keywords
gene
vectors
discovery
mutagenesis
novel
Prior art date
Application number
AT99914126T
Other languages
English (en)
Inventor
Brian Zambrowicz
Glenn Friedrich
Arthur Sands
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/057,328 external-priority patent/US6080576A/en
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE400660T1 publication Critical patent/ATE400660T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT99914126T 1998-03-27 1999-03-26 Vektoren für genmutagenese und genentdeckung ATE400660T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7972998P 1998-03-27 1998-03-27
US09/057,328 US6080576A (en) 1998-03-27 1998-04-08 Vectors for gene trapping and gene activation
US8172798P 1998-04-14 1998-04-14

Publications (1)

Publication Number Publication Date
ATE400660T1 true ATE400660T1 (de) 2008-07-15

Family

ID=27369230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99914126T ATE400660T1 (de) 1998-03-27 1999-03-26 Vektoren für genmutagenese und genentdeckung

Country Status (8)

Country Link
EP (1) EP1066392B1 (de)
JP (1) JP3725782B2 (de)
AT (1) ATE400660T1 (de)
AU (1) AU751520B2 (de)
CA (1) CA2323834C (de)
DE (1) DE69939056D1 (de)
DK (1) DK1066392T3 (de)
WO (1) WO1999050426A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332338B2 (en) 1996-10-04 2008-02-19 Lexicon Pharmaceuticals, Inc. Vectors for making genomic modifications
US7316923B1 (en) 1997-09-26 2008-01-08 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
US6897066B1 (en) 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
AU2004203361B2 (en) * 1998-03-27 2007-05-10 Lexicon Pharmaceuticals, Inc. Vectors for gene mutagenesis and gene discovery by gene trapping
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
US6808921B1 (en) 1998-03-27 2004-10-26 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
AU772677B2 (en) * 1998-03-27 2004-05-06 Lexicon Pharmaceuticals, Inc. Vectors for gene mutagenesis and gene discovery
US6218123B1 (en) 1998-08-10 2001-04-17 Lexicon Genetics Incorporated Construction of normalized cDNA libraries from eucaryotic cells
EP1584689A1 (de) * 1998-11-20 2005-10-12 Lexicon Genetics Incorporated Vektoren für die Gen-Mutagenese und die Entdeckung von Genen
CN1384881A (zh) * 1999-02-19 2002-12-11 阿瑟西斯公司 非靶向活化内源基因的组合物和方法
ATE460492T1 (de) 1999-07-14 2010-03-15 Transgenic Inc ßGEN-FALLEN-VEKTORß UND VERFAHREN ZUM ßEINFANGENß VON GENEN MITTELS DIESES VEKTORS
EP1092768A1 (de) * 1999-10-16 2001-04-18 ARTEMIS Pharmaceuticals GmbH Konstrukt zum bedingten einfangen und Disruption von Genen
ATE312173T1 (de) * 2000-03-20 2005-12-15 Newlink Genetics Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen
US6897020B2 (en) 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
GB0018876D0 (en) 2000-08-01 2000-09-20 Applied Research Systems Method of producing polypeptides
WO2002040685A2 (en) * 2000-11-16 2002-05-23 Cornell Research Foundation, Inc. Vectors for conditional gene inactivation
WO2002053732A2 (en) * 2000-12-28 2002-07-11 Pangenex Methods for making polynucleotide libraries, polynucleotide arrays, and cell librraries for high-throughput genomics analysis
EP1450602B1 (de) * 2001-03-28 2008-08-27 Dana-Farber Cancer Institute, Inc. Identifizierung und charakterisierung von genen
JP2005500847A (ja) 2001-08-24 2005-01-13 アドバンスド セル テクノロジー、インコーポレイテッド 分化誘導薬の同定のためのスクリーニング検定及び細胞治療用の分化細胞の調製
US20040091936A1 (en) 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
US7205148B2 (en) * 2003-06-11 2007-04-17 Regeneron Pharmaceuticals, Inc. Genome mutation by intron insertion into an embryonic stem cell genome
KR100747381B1 (ko) * 2006-01-20 2007-08-07 미쓰비시덴키 가부시키가이샤 엘리베이터의 그룹 관리 제어 장치
JP4867012B2 (ja) * 2007-03-22 2012-02-01 国立大学法人群馬大学 レトロウイルス産生用ベクター
CA2732498A1 (en) * 2008-07-30 2010-02-04 Michael Strathmann Methods for gene targeting
CN112824529B (zh) * 2019-11-21 2022-09-09 北京大学 一种条件性基因敲除或者拯救方法
US20230287458A1 (en) * 2020-07-14 2023-09-14 Abeona Therapeutics Inc. Recombinant adeno-associated viral vectors for multipartite gene delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4328397A (en) * 1996-08-23 1998-03-06 Chiron Corporation Human polyhomeotic 1 ((hph1)) acts as an oncogene
US6207371B1 (en) * 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same

Also Published As

Publication number Publication date
DE69939056D1 (de) 2008-08-21
AU3203699A (en) 1999-10-18
EP1066392A1 (de) 2001-01-10
DK1066392T3 (da) 2008-08-25
AU751520B2 (en) 2002-08-15
JP2002509727A (ja) 2002-04-02
CA2323834A1 (en) 1999-10-07
CA2323834C (en) 2009-01-27
JP3725782B2 (ja) 2005-12-14
EP1066392B1 (de) 2008-07-09
WO1999050426A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
DE69927046D1 (de) Vektoren für die gen-mutagenese und die entdeckung von genen durch 'gene-trapping'
DE69939056D1 (de) Vektoren für genmutagenese und genentdeckung
BR9907036A (pt) Caixa de bateria, e, bateria.
DE69900623D1 (de) Lyse von mikrobiele Zellen
ATE512095T1 (de) Zigarettenpackung
TR199700803T1 (xx) Trombin-inhibit�rleri olarak yeni dipeptidik amidinler.
NL188127C (nl) Elektrochemische cel.
DE69535352D1 (de) Expression der bazillus thuringiensis cry-proteine in pflanzen-plastiden
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
TR199901653T2 (xx) Fitalazinonlar.
TR200002445T2 (tr) Fosfolipaz inhibitörleri.
DE19875046I1 (de) Phenylcarbamate
DE60143064D1 (de) Ionenkanal-Assayverfahren
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
TR200100426T2 (tr) Nematisit pirazoller
SE9902233L (sv) A porous electrode
ATE380249T1 (de) Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen
DE60228609D1 (de) Identifizierung und charakterisierung von genen
IT1141184B (it) Elettrodo attivo,cella elettrochimica comprendente detto elettrodo e metodo di fabbricazione dell'elettrodo
ATE284140T1 (de) Konservierung von zellen
DK1151082T3 (da) Sebocytter, sebocyt-cellelinie og anvendelsen heraf
ATE373095T1 (de) Mutierte muskelspezifische enhancer
ATE544847T1 (de) Verwendung von dendritischen zellen, die interleukin 12 (il-12) exprimieren
FR2603302A1 (fr) Nouvelles souches de bacillus brevis et leur application
TR200100013T2 (tr) N-tert-butilhidroksilaminin yeni tuzları.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties